13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001599882
Total reported value
$1.1B
$1.1B
95 檔
20.0%
In Q3 2024, Rhenman & Partners Asset Management AB's U.S. equity holdings reached a combined market value of $1.1B, distributed across 95 disclosed stock positions.
Rhenman & Partners Asset Management AB executed strategic sector rebalancing during Q3 2024, establishing 8 new positions while fully exiting 6 holdings and trimming 39 positions.
In terms of portfolio concentration, the top 5 core holdings (including BSX, UNH, LLY) accounted for 20.0% of total reported equity market value during Q3 2024.
Top New Position Initiated
NVO
市值: $11.9M
Top Position Liquidated / Trimmed
EW
前期市值: $9.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BSX | Boston Scientific CORP | Stock-Healthcare | 4.01% | -3.03% | -0.84% | |
| 2 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 3.45% | +2.15% | -30.96% | |
| 3 | LLY | Eli Lilly & Co | Stock-Healthcare | 3.42% | -1.30% | +1.06% | |
| 4 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 3.33% | -2.98% | +21.88% | |
| 5 | THC | Tenet Healthcare CORP | Stock-Healthcare | 2.99% | +0.24% | -3.32% | |
| 6 | PRCT | Procept Biorobotics CORP | Stock-Other | 2.89% | -0.73% | +1.14% | |
| 7 | ABBV | Abbvie Inc | Stock-Healthcare | 2.84% | +0.38% | -6.35% | |
| 8 | MDT | Medtronic plc | Stock-Healthcare | 2.69% | +0.11% | +76.92% | |
| 9 | EXK | Exact Sciences CORP | Stock-Materials | 2.57% | — | +220.69% | |
| 10 | HCA | Hca Healthcare Inc | Stock-Healthcare | 2.51% | — | -7.04% | |
| 11 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 2.51% | -0.80% | +4.13% | |
| 12 | GILD | Gilead Sciences Inc | Stock-Healthcare | 2.49% | -0.75% | +53.67% | |
| 13 | NTRA | Natera Inc | Stock-Healthcare | 2.38% | +0.29% | +47.13% | |
| 14 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 2.36% | +0.13% | -28.08% | |
| 15 | MRK | Merck & Co. Inc. | Stock-Healthcare | 2.22% | +2.59% | NEW | |
| 16 | BDX | Becton Dickinson And Co | Stock-Healthcare | 2.20% | — | -0.44% | |
| 17 | ELV | Elevance Health Inc | Stock-Healthcare | 2.13% | +0.10% | -41.14% | |
| 18 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 2.09% | — | +617.65% | |
| 19 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 2.08% | +0.13% | +44.93% | |
| 20 | COO | Cooper Cos Inc/the | Stock-Healthcare | 2.04% | -0.07% | -26.45% | |
| 21 | ALHC | Alignment Healthcare Inc | Stock-Other | 1.90% | -0.05% | +20.46% | |
| 22 | DHR | Danaher CORP | Stock-Healthcare | 1.88% | +1.02% | +71.76% | |
| 23 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 1.80% | -0.96% | -11.57% | |
| 24 | RPRX | Royalty Pharma plc | Stock-Healthcare | 1.41% | -0.34% | +12.63% | |
| 25 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 1.26% | -1.02% | +4.58% | |
| 26 | ABT | Abbott Laboratories | Stock-Healthcare | 1.25% | -0.60% | -6.90% | |
| 27 | ITCIEUR | Intra-cellular Therapies Inc | Stock-Other | 1.22% | — | +44.72% | |
| 28 | MCK | Mckesson CORP | Stock-Healthcare | 1.21% | -0.62% | +0.39% | |
| 29 | GKOS | Glaukos CORP | Stock-Healthcare | 1.17% | +0.45% | +122.00% | |
| 30 | CI | THE Cigna Group | Stock-Healthcare | 1.17% | +0.19% | -43.80% | |
| 31 | ALGN | Align Technology Inc | Stock-Healthcare | 1.14% | +0.84% | -2.65% | |
| 32 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.12% | -0.92% | -41.11% | |
| 33 | DVAX | Dynavax Technologies CORP | Stock-Other | 1.08% | — | -3.44% | |
| 34 | BIIB | Biogen Inc | Stock-Healthcare | 1.06% | -0.54% | -20.87% | |
| 35 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 0.97% | — | — | |
| 36 | CVS | Cvs Health CORP | Stock-Healthcare | 0.94% | -0.25% | — | |
| 37 | IQV | Iqvia Holdings Inc | Stock-Healthcare | 0.92% | -1.12% | EXIT | |
| 38 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 0.89% | +0.13% | -3.92% | |
| 39 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 0.86% | — | +563.42% | |
| 40 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 0.84% | +0.22% | -18.42% | |
| 41 | MOH | Molina Healthcare Inc | Stock-Healthcare | 0.83% | +0.47% | NEW | |
| 42 | COR | Cencora Inc | Stock-Healthcare | 0.82% | -0.78% | -12.33% | |
| 43 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 0.80% | -0.22% | +14.40% | |
| 44 | HUM | Humana Inc | Stock-Healthcare | 0.80% | — | — | |
| 45 | CYTK | Cytokinetics Inc | Stock-Healthcare | 0.77% | — | -8.61% | |
| 46 | INSM | Insmed Inc | Stock-Healthcare | 0.77% | -1.69% | +30.15% | |
| 47 | PODD | Insulet CORP | Stock-Healthcare | 0.76% | +0.24% | -13.98% | |
| 48 | NUVL | Nuvalent Inc-a | Stock-Other | 0.75% | -1.03% | EXIT | |
| 49 | CNC | Centene CORP | Stock-Healthcare | 0.71% | +1.48% | NEW | |
| 50 | SYK | Stryker CORP | Stock-Healthcare | 0.67% | -0.01% | +27.78% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | EXK | Exact Sciences CORP | +2% | +220.69% | Add |
| 2 | INSP | Inspire Medical Systems Inc | +1.9% | +617.65% | Add |
| 3 | MDT | Medtronic plc | +1.1% | +76.92% | Add |
| 4 | NVO | Novo-nordisk A/s-spons Adr | +1% | NEW | New buy |
| 5 | CVS | Cvs Health CORP | +0.9% | NEW | New buy |
| 6 | GILD | Gilead Sciences Inc | +0.9% | +53.67% | Add |
| 7 | HUM | Humana Inc | +0.8% | NEW | New buy |
| 8 | NTRA | Natera Inc | +0.8% | +47.13% | Add |
| 9 | DHR | Danaher CORP | +0.7% | +71.76% | Add |
| 10 | ALHC | Alignment Healthcare Inc | +0.7% | +20.46% | Add |
| 11 | APLSUSD | Apellis Pharmaceuticals Inc | +0.7% | +563.42% | Add |
| 12 | MOH | Molina Healthcare Inc | +0.6% | +322.86% | Add |
| 13 | GKOS | Glaukos CORP | +0.6% | +122.00% | Add |
| 14 | EVH | Evolent Health Inc - A | +0.5% | +430.00% | Add |
| 15 | BNTX | Biontech Se-adr | +0.5% | NEW | New buy |
| 16 | TMDX | Transmedics Group Inc | +0.4% | +235.33% | Add |
| 17 | GERN | Geron CORP | +0.4% | NEW | New buy |
| 18 | DNTH | Dianthus Therapeutics Inc | +0.3% | NEW | New buy |
| 19 | PRCT | Procept Biorobotics CORP | +0.3% | +1.14% | Add |
| 20 | ITCIEUR | Intra-cellular Therapies Inc | +0.3% | +44.72% | Add |
| 21 | IQV | Iqvia Holdings Inc | +0.3% | +54.84% | Add |
| 22 | ACHC | Acadia Healthcare Co Inc | +0.3% | +165.54% | Add |
| 23 | IMVT | Immunovant Inc | +0.2% | +86.21% | Add |
| 24 | ACLXGBX | Arcellx Inc | +0.2% | NEW | New buy |
| 25 | BRKR | Bruker CORP | +0.2% | +638.58% | Add |
| 26 | NRIX | Nurix Therapeutics Inc | +0.2% | +72.03% | Add |
| 27 | NUVL | Nuvalent Inc-a | +0.2% | +8.76% | Add |
| 28 | IDYA | Ideaya Biosciences Inc | +0.2% | +138.32% | Add |
| 29 | UHS | Universal Health Services-b | +0.2% | NEW | New buy |
| 30 | MRK | Merck & Co. Inc. | +0.1% | +37.71% | Add |
| 31 | INSM | Insmed Inc | +0.1% | +30.15% | Add |
| 32 | RLAY | Relay Therapeutics Inc | +0.1% | +100.00% | Add |
| 33 | 1K0 | Igm Biosciences Inc | +0.1% | -4.89% | Trim |
| 34 | REGN | Regeneron Pharmaceuticals | +0.1% | +21.88% | Add |
| 35 | BBIO | Bridgebio Pharma Inc | +0.1% | +45.26% | Add |
| 36 | MEDP | Medpace Holdings Inc | +0.1% | +200.00% | Add |
| 37 | BMRN | Biomarin Pharmaceutical Inc | +0.1% | +44.93% | Add |
| 38 | IOVA | Iovance Biotherapeutics Inc | +0.1% | +14.40% | Add |
| 39 | SYK | Stryker CORP | +0.1% | +27.78% | Add |
| 40 | THC | Tenet Healthcare CORP | +0.1% | -3.32% | Trim |
| 41 | IONS | Ionis Pharmaceuticals Inc | 0% | +50.00% | Add |
| 42 | RPRX | Royalty Pharma plc | 0% | +12.63% | Add |
| 43 | RGEN | Repligen CORP | — | — | Unchanged |
| 44 | TMO | Thermo Fisher Scientific Inc | 0% | +4.58% | Add |
| 45 | EHC | Encompass Health CORP | 0% | +1.67% | Add |
| 46 | EPIEUR | Essa Pharma Inc | 0% | -0.17% | Trim |
| 47 | TECH | Bio-techne CORP | 0% | — | Unchanged |
| 48 | PLRX | Pliant Therapeutics Inc | 0% | — | Unchanged |
| 49 | HCA | Hca Healthcare Inc | 0% | -7.04% | Trim |
| 50 | XENE | Xenon Pharmaceuticals Inc | 0% | — | Unchanged |
According to official SEC Form 13F filings, Rhenman & Partners Asset Management AB reported a total U.S. public equity portfolio value of $1.1B across 95 disclosed positions in Q3 2024.
During Q3 2024, Rhenman & Partners Asset Management AB's top holdings by market value included BSX (4.0%)、UNH (3.5%)、LLY (3.4%). The largest single position, BSX, represented 4.0% of total portfolio value.
In Q3 2024, Rhenman & Partners Asset Management AB made 92 total portfolio adjustments, initiating 8 new buys, adding to 39 positions, trimming 39 holdings, and fully liquidating 6 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.